Glycated apolipoprotein B and myocardial infarction

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 17, Issue 1, 2007, Pages 6-12

  Misciagna, G ^a   Logroscino, G ^b   De Michele, G ^a   Guerra, V ^a   Cisternino, A M ^a   Caruso, M G ^a   Trevisan, M ^c  

^a NATIONAL INSTITUTE FOR DIGESTIVE DISEASES   (Italy)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

Author keywords

Apolipoprotein B; Cohort study; Glycation; Myocardial infarction

Indexed keywords

GLYCOSYLATED LIPOPROTEINS, LDL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

AGED; ARTICLE; ATHEROSCLEROSIS; BLOOD; CASE CONTROL STUDY; COHORT ANALYSIS; ELECTROCARDIOGRAPHY; FEMALE; HEART INFARCTION; HUMAN; MALE; MIDDLE AGED; MORTALITY; RISK; STATISTICAL MODEL;

AGED; ATHEROSCLEROSIS; CASE-CONTROL STUDIES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; COHORT STUDIES; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; LIPOPROTEINS, LDL; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; ODDS RATIO;

EID: 33845417201     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2006.09.005     Document Type: Article

References (24)

1. Aronson D., and Johnstone M.T. Coronary artery disease in diabetes. In: Johnstone M.T., and Veves A. (Eds). Diabetes and cardiovascular disease (2001), Humana Press, Totowa, NJ 247-279
2. Lyons T.J., Thorpe S.R., and Baynes J.W. Glycation and autoxidation of proteins in aging and diabetes. In: Ruderman N., Williamson J., and Brownlee M. (Eds). Hyperglycaemia, diabetes, and vascular disease (1992), Oxford University Press, Oxford, UK 197-217
3. Lyons T.J. Lipoprotein glycation and its metabolic consequences. Diabetes 41 Suppl. 2 (1992) 67-73
4. Kortlandt W., van Rijn H.J.M., and Erkelens D.W. Glycation and lipoproteins. Diab Nutr Metab 6 (1993) 231-239
5. Schleicher E., Deufel T., and Wieland O.H. Non-enzymatic glycosylation of human serum lipoproteins. FEBS Lett 129 (1981) 1-4
6. Tames F.J., Mackness M.I., Arrol S., Laing I., and Durrington P.N. Non-enzymatic glycation of apolipoprotein B in the sera of diabetic and non-diabetic subjects. Atherosclerosis 93 (1992) 237-244
7. Cohen M.P., Lautenslager G., and Shea E. Glycated LDL concentrations in non-diabetic and diabetic subjects measured with monoclonal antibodies reactive with glycated apolipoprotein B epitopes. Eur J Clin Chem Clin Biochem 31 (1993) 707-713
8. Akanji A.O., Abdella N., and Mojiminiyi O.A. Determinants of glycated LDL levels in non-diabetic and diabetic hyperlipidaemic patients in Kuwait. Clin Chim Acta 317 (2002) 171-176
9. Stitt A.W., He C., Friedman S., Scher L., Rossi P., Ong L., et al. Elevated AGE-modified ApoB in sera of euglycemic, normolipidemic patients with atherosclerosis: relationship to tissue AGEs. Mol Med 3 (1997) 617-627
10. Kiuchi K., Nejima J., Takano T., Ohta M., and Hashimoto H. Increased serum concentrations of advanced glycation end products: a marker of coronary artery disease activity in type 2 diabetic patients. Heart 85 (2001) 87-91
11. Kanauchi M., Tsujimoto N., and Hashimoto T. Advanced glycation end products in non-diabetic patients with coronary artery disease. Diabetes Care 24 (2001) 1620-1623
12. Witzum J.L., Mahoney E.M., Branks M.J., Fisher M., Elam R., and Steinberg D. Non-enzymatic glucosylation of low-density lipoprotein alters its biological activity. Diabetes 31 (1982) 283-291
13. Triau J.E., Arbetter J., and Schaefer E.J. Impaired hepatocyte binding, uptake and degradation of glucosylated low-density lipoproteins. Biochim Biophys Acta 877 (1986) 359-365
14. Millican S.A., Schultz D., Bagga M., Coussons P.J., Muller K., and Hunt J.V. Glucose-modified low density lipoprotein enhances human monocyte chemotaxis. Free Rad Res 28 (1998) 533-542
15. Lopes-Virella M.F., Klein R.L., Lyons T.J., Stevenson H.C., and Witzum J.L. Glycosylation of low-density lipoprotein enhances cholesteryl ester synthesis and accumulation in human monocyte-derived macrophages. Diabetes 37 (1988) 550-557
16. Ferretti G., Rabini R.A., Bacchetti T., Vignini A., Salvolini E., Ravaglia F., et al. Glycated low density lipoproteins modify platelet properties: a compositional and functional study. J Clin Endocrinol Metab 87 (2002) 2180-2184
17. Mullarkey C.J., Edelstein D., and Brownlee M. Free radical generation by early glycation products: a mechanism for accelerated atherogenesis in diabetes. Biochem Biophys Res Comm 173 (1990) 932-939
18. Bowie A., Owens D., Collins P., Johnson A., and Tomkin G.H. Glycosylated low density lipoproteins is more sensitive to oxidation: implications for the diabetic patients. Atherosclerosis 102 (1993) 63-67
19. Krauss R.M. Lipids and lipoproteins in patients with type II diabetes. Diabetes Care 27 (2004) 1496-1504
20. Matsui H., Okumura K., Toki Y., and Hayakawa T. Low-density lipoprotein particle size as an independent predictor of glycated low-density lipoprotein level. Diabetes Care 22 (1999) 1220-1221
21. La Belle M., and Krauss R.M. Differences in carbohydrate content of low density lipoproteins associated with low density lipoprotein subclass pattern. J Lipid Res 31 (1990) 1577-1588
22. Misciagna G., Leoci C., Elba S., Petruzzi J., Guerra V., Mossa A., et al. The epidemiology of cholelithiasis in southern Italy. Eur J Gastroenterol Hepatol 6 (1994) 937-941
23. National Cholesterol Education Program. Detection, evaluation, and treatment of high blood cholesterol in adults. Circulation 105 (2002) 3169-3171
24. Ravnskov U. The cholesterol myths (2000), New Trends Publishing, Washington, DC p. 47-95